Correction to: Cell Death and Disease (2021) 12:1067 https://doi.org/10.1038/s41419-021-04347-7, published online 09 November 2021
Since the publication of this paper, the authors have noted that there was an error Figure 4C. In that, the representative immunochemical staining image for c-myc of the NC group was misused. This error has now been rectified. The correct figure is shown below.
The incorrect figure is shown below.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, G., Zou, J., Shi, J. et al. Correction: Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells. Cell Death Dis 15, 1 (2024). https://doi.org/10.1038/s41419-023-06384-w
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-023-06384-w
This article is cited by
-
Defining treatment-resistant brain cancer: Genetic screening to identify oncogene-driven immunomodulation and therapy resistance
Cancer Gene Therapy (2026)
-
FSTL3 is a biomarker of poor prognosis and associated with immunotherapy resistance in ovarian cancer
Journal of Experimental & Clinical Cancer Research (2025)
-
Optimizing viral transduction in immune cell therapy manufacturing: key process design considerations
Journal of Translational Medicine (2025)
-
MT2A promotes angiogenesis in chronically ischemic brains through a copper–mitochondria regulatory mechanism
Journal of Translational Medicine (2025)
-
The interplay of DNA damage, epigenetics and tumour heterogeneity in driving cancer cell fitness
Nature Communications (2025)
